Eisai
4523.T
#2139
Rank
S$11.54 B
Marketcap
S$40.91
Share price
3.89%
Change (1 day)
10.12%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): S$2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.11. In 2022 the company made an earnings per share (EPS) of S$2.05 a decrease over its 2021 EPS that were of S$9.12.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$2.9644.16%
2022S$2.05-77.48%
2021S$9.12-41.88%
2020S$15.68-0.94%
2019S$15.8352.59%
2018S$10.38124.17%
2017S$4.63-49.42%
2016S$9.1537.08%
2015S$6.68-11.75%
2014S$7.57-3.23%
2013S$7.82-18.56%
2012S$9.60-15.51%
2011S$11.36-3.75%
2010S$11.81-1.36%
2009S$11.97